Figure 1 shows a case of BRAF-mutated MM patient, with a diffusely metastatic disease at staging, showing metabolic response at 18F-FDG PET/CT after anti BRAF/MEK therapy. The gene discussed is BRAF; the disease is metastatic neoplasm.